,3 Based on confirmatory cord blood genetic testing demonstrating homozygous deletion of SMN on chromosome 5q and three copies of the SMN2 gene, it was determined that our patient was at risk for development of symptomatic SMA. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.